Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    14693724 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
2 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
3 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)

Indicates status has not been verified in more than two years